Half-year report · Q2
8095.TEDINET S100WCCI
Period2024-12-01 → 2025-05-31
Filed2025-07-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥30.1bn | 2024-12-01 → 2025-05-31 | Cons. | Net sales |
| Revenue | ¥58.0bn | 2023-12-01 → 2024-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥28.1bn | 2023-12-01 → 2024-05-31 | Cons. | Net sales |
| Operating income | ¥2.2bn | 2024-12-01 → 2025-05-31 | Cons. | Operating income |
| Operating income | ¥1.3bn | 2023-12-01 → 2024-05-31 | Cons. | Operating income |
| Ordinary income | ¥2.1bn | 2024-12-01 → 2025-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2023-12-01 → 2024-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2023-12-01 → 2024-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.0bn | 2024-12-01 → 2025-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.1bn | 2023-12-01 → 2024-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.3bn | 2024-12-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.5bn | 2023-12-01 → 2024-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥704m | 2023-12-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.3bn | 2024-12-01 → 2025-05-31 | Cons. | Profit loss |
| Net income | ¥701m | 2023-12-01 → 2024-05-31 | Cons. | Profit loss |
| Total assets | ¥65.5bn | at 2025-05-31 | Cons. | Assets |
| Total assets | ¥64.6bn | at 2024-11-30 | Cons. | Assets |
| Total assets | ¥66.5bn | at 2024-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥39.5bn | at 2025-05-31 | Cons. | Liabilities |
| Total liabilities | ¥39.3bn | at 2024-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥26.0bn | at 2025-05-31 | Cons. | Net assets |
| Net assets / equity | ¥25.3bn | at 2024-11-30 | Cons. | Net assets |
| Net assets / equity | ¥29.1bn | at 2024-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.3bn | at 2025-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.1bn | at 2024-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.2bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.0bn | at 2024-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2024-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2023-11-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.1bn | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.8bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.3bn | 2023-12-01 → 2024-05-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.6bn | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.9bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2023-12-01 → 2024-05-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥775m | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.7bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.9bn | 2023-12-01 → 2024-05-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥31.97 | 2024-12-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-63.18 | 2023-12-01 → 2024-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.75 | 2023-12-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 39.5% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.0% | at 2024-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.5% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-12-01 → 2025-05-31 | ¥25m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-12-01 → 2025-05-31 | ¥17m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-12-01 → 2025-05-31 | −¥202m |
| Reconciling Itemsreconciling | revenue | 2024-12-01 → 2025-05-31 | −¥529m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-12-01 → 2025-05-31 | −¥529m |
| Reconciling Itemsreconciling | segment profit | 2024-12-01 → 2025-05-31 | ¥139m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥11.9bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥11.6bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥319m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥871m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥8.1bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥8.0bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥48m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥544m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥4.5bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥4.5bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥1m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥190m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥6.2bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥6.0bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥152m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥679m |
| —segment total | revenue | 2024-12-01 → 2025-05-31 | ¥30.6bn |
| —segment total | revenue external | 2024-12-01 → 2025-05-31 | ¥30.1bn |
| —segment total | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥521m |
| —segment total | segment profit | 2024-12-01 → 2025-05-31 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-12-01 → 2025-05-31 | ¥30.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-12-01 → 2025-05-31 | ¥30.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥529m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-12-01 → 2025-05-31 | ¥2.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-12-01 → 2024-05-31 | ¥26m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-12-01 → 2024-05-31 | ¥18m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-12-01 → 2024-05-31 | −¥51m |
| Reconciling Itemsreconciling | revenue | 2023-12-01 → 2024-05-31 | −¥739m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-12-01 → 2024-05-31 | −¥739m |
| Reconciling Itemsreconciling | segment profit | 2023-12-01 → 2024-05-31 | ¥30m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2023-12-01 → 2024-05-31 | ¥10.9bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2023-12-01 → 2024-05-31 | ¥10.4bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥495m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2023-12-01 → 2024-05-31 | ¥0 |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2023-12-01 → 2024-05-31 | ¥6.8bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2023-12-01 → 2024-05-31 | ¥6.7bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥60m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2023-12-01 → 2024-05-31 | ¥198m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2023-12-01 → 2024-05-31 | ¥5.6bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2023-12-01 → 2024-05-31 | ¥5.6bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥35m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2023-12-01 → 2024-05-31 | ¥551m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2023-12-01 → 2024-05-31 | ¥5.6bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2023-12-01 → 2024-05-31 | ¥5.4bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥140m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2023-12-01 → 2024-05-31 | ¥616m |
| —segment total | revenue | 2023-12-01 → 2024-05-31 | ¥28.8bn |
| —segment total | revenue external | 2023-12-01 → 2024-05-31 | ¥28.1bn |
| —segment total | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥731m |
| —segment total | segment profit | 2023-12-01 → 2024-05-31 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-12-01 → 2024-05-31 | ¥28.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-12-01 → 2024-05-31 | ¥28.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥739m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-12-01 → 2024-05-31 | ¥1.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 615
| Item | Context | Value | Unit |
|---|---|---|---|
| Capital surplus | CurrentQuarterInstant | 6346000000 | JPY |
| Retained earnings | Prior1YearInstant | 12229000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 13127000000 | JPY |
| Treasury stock | Prior1YearInstant | -255000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -255000000 | JPY |
| Shareholders equity | Prior1YearInstant | 22900000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 23848000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 1388000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 1229000000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | -2000000 | JPY |
| Deferred gains or losses on hedges | CurrentQuarterInstant | -0 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 319000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 273000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 560000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 518000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 2265000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 2021000000 | JPY |
| Non controlling interests | Prior1YearInstant | 136000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 160000000 | JPY |
| Net assets | Prior1YearInstant | 25302000000 | JPY |
| Net assets | CurrentQuarterInstant | 26030000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 64595000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 65536000000 | JPY |
| Net sales | Prior1YTDDuration | 28091000000 | JPY |
| Net sales | CurrentYTDDuration | 30102000000 | JPY |
| Cost of sales | Prior1YTDDuration | 18900000000 | JPY |
| Cost of sales | CurrentYTDDuration | 19213000000 | JPY |
| Gross profit | Prior1YTDDuration | 9191000000 | JPY |
| Gross profit | CurrentYTDDuration | 10889000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 7845000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 8666000000 | JPY |
| Operating income | Prior1YTDDuration | 1345000000 | JPY |
| Operating income | CurrentYTDDuration | 2222000000 | JPY |
| Interest and dividends income noi | Prior1YTDDuration | 28000000 | JPY |
| Interest and dividends income noi | CurrentYTDDuration | 30000000 | JPY |
| Equity in earnings of affiliates noi | Prior1YTDDuration | － | JPY |
| Equity in earnings of affiliates noi | CurrentYTDDuration | 9000000 | JPY |
| Office work fee noi | Prior1YTDDuration | 0 | JPY |
| Office work fee noi | CurrentYTDDuration | 65000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | － | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 29000000 | JPY |
| Other noi | Prior1YTDDuration | 71000000 | JPY |
| Other noi | CurrentYTDDuration | 61000000 | JPY |
| Non operating income | Prior1YTDDuration | 100000000 | JPY |
| Non operating income | CurrentYTDDuration | 195000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 32000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 71000000 | JPY |
| Equity in losses of affiliates noe | Prior1YTDDuration | 8000000 | JPY |
| Equity in losses of affiliates noe | CurrentYTDDuration | － | JPY |
| Commission for syndicate loan noe | Prior1YTDDuration | 6000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |